Journal article
Management of osteoarthritis in general practice in Australia
CA Brand, C Harrison, J Tropea, RS Hinman, H Britt, K Bennell
Arthritis Care and Research | Published : 2014
DOI: 10.1002/acr.22197
Abstract
Objective To describe management of osteoarthritis (OA) of the hip (OA-hip) and knee (OA-knee) by Australian general practitioners (GPs). Methods We analyzed data from the Bettering the Evaluation and Care of Health program, from April 1, 2005 to March 31, 2010. Patient and GP characteristics and encounter management data were extracted. Data were classified by the International Classification of Primary Care, version 2, and summarized using descriptive statistics and 95% confidence intervals around point estimates. Results There were 489,900 GP encounters at which OA was managed (rate of 26.4 per 1,000 encounters). OA-hip was managed at a rate of 2.3 per 1,000 encounters (n = 1,106, 8.6% OA..
View full abstractGrants
Funding Acknowledgements
Supported by a grant from the Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne. The Bettering the Evaluation and Care of Health program was supported (between 2005 and 2010) by Abbott Australasia, AstraZeneca (Australia), the Australian Government Department of Health and Ageing, the Australian Government Department of Veterans' Affairs, the Australian Institute of Health and Welfare, Sanofi-Aventis Australia, Janssen-Cilag, Merck, Sharpe and Dohme (Australia), National Occupational Health and Safety Commission, National Prescribing Service, Novartis Pharmaceuticals Australia, Pfizer Australia, GlaxoSmithKline Australia, Roche Products, and Wyeth Australia. Dr. Bennell's work is supported in part by an Australian Research Council Future Fellowship.